Over 100 million people in India have diabetes, according to a recent study published in The Lancet. The study also notes that the number of diabetes cases worldwide could jump to 1.3 billion by 2050. Indian startups are taking the lead in innovative solutions to address this epidemic Based in...
ZEISS, QMS Medical, to Screen for Diabetic Retinopathy in India
Zeiss Medical Technology India, a subsidiary of Carl Zeiss Meditec of Germany, announced a strategic arrangement with QMS Medical Ltd., based in Mumbai to screen diabetic patients for Diabetic Retinopathy, the leading cause of preventable vision loss. Diabetic retinopathy occurs when blood vessels in the retina change. This condition slowly...
Google, Verily Launch Screening for Diabetic Retinopathy in India
Google, and its affiliate, South San Francisco-based Verily (subsidiary of Google parent Alphabet), have been conducting a global clinical research program with a focus on India to screen for two conditions that impact millions of people worldwide: diabetic retinopathy and diabetic macular edema. The studies involved Aravind Eye Hospital at...